Orris

Mean platelet volume (MPV) measures platelet size in the blood, which is important because dengue fever often leads to low platelet counts, especially during the critical phase. However, predicting when a patient's platelet count will recover is challenging due to the lack of clinical data. MPV may offer a solution as it tends to rise when platelet counts fall, suggesting a possible link to bone marrow activity. This study aims to understand how MPV changes during the three phases of dengue fever and how it relates to platelet count recovery. Successful results could provide valuable markers for clinicians, helping improve patient care and management. REFRAME OWN SENTENCES IN SIMPLE LANGUAGE WITHOUT PLIAGRISM FOR THESIS ROL

Reading Document
Here is your paragraph reframed in simple, original language suitable for a thesis rationale of literature (ROL):
Reframed Version:
Platelet count drops are a well-known feature of dengue fever, particularly during its critical phase, which makes monitoring platelet levels an essential part of patient management. One challenge clinicians face is that there is currently no reliable way to predict when a patient's platelet count will begin to recover. Mean platelet volume (MPV), a simple blood test parameter that reflects the size of platelets, has shown potential in addressing this gap. Research suggests that MPV tends to increase as platelet counts decline, which may reflect the bone marrow's effort to compensate by producing larger, newer platelets. Based on this observation, this study seeks to examine how MPV behaves across all three clinical phases of dengue fever and whether its changes can be used to anticipate platelet count recovery. If a consistent pattern is identified, MPV could serve as a practical and accessible clinical marker to guide treatment decisions and improve overall patient outcomes.
Key changes made:
  • Replaced technical phrasing with plain, direct language
  • Broke complex ideas into clearer, shorter sentences
  • Removed passive or vague constructions
  • Maintained all the original scientific meaning without copying the source phrasing
  • Kept the academic tone appropriate for a thesis ROL section

To better understand the clinical characteristics of concurrent bacteremia (dual infection) in patients with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) and identify predictive risk factors for dual infection, 100 patients with DHF/DSS (7 with a dual infection and 93 with DHF/DSS alone [controls]) were enrolled in this study. A patient with DHF/DSS who lacked three or more of the five most frequently observed manifestations other than fever in controls or showed disturbed consciousness was defined as one with unusual dengue manifestations. Patients with a dual infection were older, and tended to have prolonged fever, higher frequencies of acute renal failure, gastrointestinal bleeding, altered consciousness, unusual dengue manifestations, and DSS. Acute renal failure (odds ratio [OR] = 51.45, P = 0.002), and prolonged fever (> 5 days) (OR = 26.07, P = 0.017) were independent risk factors for dual infection. Clinicians should be alert to the potential for concurrent bacteremia when treating patients with DHF/DSS who are at risk for dual infection and manage them accordingly.REFRAME IN EASY SUMMARY LANGUAGE WITHOUT PLIAGARISM FOR ROL THESIS

Medical Text Search

dengue hemorrhagic fever shock syndrome bacteremia dual infection risk factors

Medical Text Search

DHF DSS concurrent bacterial infection clinical predictors acute renal failure prolonged fever

GradeResponse
GradeResponse
Here is the passage reframed in simple, original language for your thesis ROL:
Reframed Version:
Dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) are already serious conditions on their own, but some patients may develop an additional bacterial blood infection (bacteremia) at the same time — a situation referred to as a dual infection. To explore this, a study enrolled 100 patients diagnosed with DHF or DSS, seven of whom had a confirmed dual infection, while the remaining 93 served as a comparison group. The study also introduced a definition for "unusual dengue manifestations," which applied to patients who lacked at least three of the most common dengue symptoms (excluding fever) seen in the comparison group, or who showed signs of impaired consciousness.
Findings revealed that patients with dual infections were generally older and experienced a longer duration of fever. They also showed higher rates of kidney failure, gastrointestinal bleeding, reduced consciousness, and progression to dengue shock syndrome compared to those with dengue alone. Statistical analysis identified two independent factors that significantly increased the likelihood of a dual infection: the development of acute kidney failure (which raised the odds by more than 50 times) and fever lasting longer than five days (which raised the odds by approximately 26 times).
These findings highlight the importance of clinical vigilance. When a patient with DHF or DSS presents with these warning signs, the possibility of a concurrent bacterial infection should be actively considered so that appropriate management can be initiated without delay.
Key changes made:
  • Replaced statistical jargon (OR values, P values) with plain language equivalents
  • Simplified the definition of "unusual dengue manifestations" for a general academic audience
  • Restructured sentences to eliminate any similarity with the original phrasing
  • Maintained full scientific accuracy while improving readability
  • Kept the conclusion practical and clinically meaningful, suitable for a thesis ROL section
This is a shared conversation. Sign in to Orris to start your own chat.